Here's How America's Baby Boomers Get Their Weed

This demographic is loaded, and they're spending big bucks on these expensive forms of marijuana

Since the Summer of Love in 1967, San Francisco has served as the epicenter of the counterculture and rock 'n' roll.

And from that day until... pretty recently, any time you went to a rock show, no matter if the band was an established act or a fresh up-and-comer, you could count on one thing...

The smell of burning marijuana.

That's why two recent rock concerts my wife and I attended in San Francisco really jumped out at me - not once in two evenings spanning several hours at large venues did we smell any cannabis.

Don't get me wrong: I suspect plenty of folks were imbibing cannabis. After all, California made recreational use legal Jan. 1 after 20 years as a medical-only state.

But something much bigger was going on, right there at the concert.

So let me tell you why our experience was mind-blowing and eye-opening in more ways than one...

[mmpazkzone name="in-story" network="9794" site="307044" id="137008" type="4"]

Why San Francisco Is a Lot Less "Foggy" These Days

What my wife and I were witnessing - and not smelling - was nothing less than the rise of one of the most significant, high-profit trends in the entire multibillion-dollar legal weed segment...

Something I like to call the "precision dose market."

Simply stated, folks are moving away from smoking pot in favor of edibles or vaporizing oils or "wax."

RELATED: Top five tiny Canadian pot stocks are set to skyrocket. Click here...

Though they can't at present cite meaningful data, dispensaries in the Golden State report growing demand for both vape cartridges and edibles.

That says a lot because both forms may cost two or three times what an "eighth," or a standard 1/8 ounce portion of marijuana buds, goes for - around $45 or so.

Part of this no doubt stems from the fact that more and more people are choosing a healthier approach.

You see, most new marijuana users, smartly, don't want any kind of smoke entering their lungs. And they want to know exactly what it is they're taking. So, the new generation of products don't just come smoke-free - their dosage is often precisely measured.

As marijuana goes mainstream, users are looking to be healthier, more discreet, and more precise in their dosing.

Just look at what's going on with the baby boomers...

Looking for Smarter Ways to Get Cannabis

Many of this cohort of folks, which numbers anywhere from 74 million to 83 million, depending on where you peg their birth year, got rid of their bowls, bongs, and rolling papers years ago as they embarked on careers and raised families.

Only now, with the rise of healthy options, and, perhaps, a bit more free time on their hands, they are using cannabis once again.

A recent report by Ohio State University notes that as much as 70% of the 50-and-older demographic is using some form of alternative medicine.

And now that the legal weed "genie" is out of the bottle, many boomers now see cannabis as a bona fide alternative medicine that helps with everything from anxiety to insomnia.

Make no mistake: This is a massively powerful group of consumers. The American Association of Retired Persons says baby boomers account for fully two-thirds of U.S. disposable income and are set to inherit $15 trillion dollars in the next 20 years.

If boomers were their own country, that windfall would put them somewhere between India and the United States in terms of gross domestic product by purchasing power parity.

In other words, they have plenty of money to buy the very best in cannabis, and an increasing amount of anecdotal evidence from the marijuana markets suggests they're doing just that.

And this is just the United States, mind you.

Here's My Favorite Small-Cap Edibles Play

In Canada, where weed is set to go totally legal in June of this year, the edible marijuana segment is expected to zoom 457%, from $1.02 billion in 2018, to $5.69 billion by 2021. That's potentially going to be like pure rocket fuel for the five tiny "north of the border" weed stocks I've researched for my Nova-X Report readers (click here to learn more about my pot stock research).

In fact, I think this small Canadian company is one of the best speculative bets on the American edible/precision dose market and the fully legal, wide open Canadian market we're watching for this summer.

Call it a "double-play."

It's called CannaRoyalty Corp. (CNSX: CRZ, OTCMKTS: CNNRF). It has three holdings that sell edibles in the rich California market - Soul Sugar Kitchen, Stocks Confections, and Care By Design.

These outlets sell everything from infused gummy candies to medicinal gourmet chocolate truffles - perfect for boomers looking to be discreet (or creative) with their cannabis consumption.

Bear in mind, this is a speculative bet; don't bet the farm on this. I think this company could be primed for explosive gains. These shares have seen peak gains of around 135% over the past 12 months before retreating somewhat, and I think we're ready for another run-up.

When Canada Takes Weed Fully Legal...

It'll probably make our retrograde attorney general hopping mad, but there's really nothing on Earth he can do to stop these small cannabis companies from hitting the stratosphere. Sessions could be furious, but folks who park a few hundred dollars into these "north of the border" firms could potentially turn a small stake into $100,000 - and fast. Michael Robinson has the details for you - click here to hear what he's got to say...

Follow Money Morning on FacebookTwitter, and LinkedIn.

About the Author

Michael A. Robinson is a 36-year Silicon Valley veteran and one of the top tech and biotech financial analysts working today. That's because, as a consultant, senior adviser, and board member for Silicon Valley venture capital firms, Michael enjoys privileged access to pioneering CEOs, scientists, and high-profile players. And he brings this entire world of Silicon Valley "insiders" right to you...

  • He was one of five people involved in early meetings for the $160 billion "cloud" computing phenomenon.
  • He was there as Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, led the robotics revolution that saved the U.S. automotive industry.
  • As cyber-security was becoming a focus of national security, Michael was with Dave DeWalt, the CEO of McAfee, right before Intel acquired his company for $7.8 billion.

This all means the entire world is constantly seeking Michael's insight.

In addition to being a regular guest and panelist on CNBC and Fox Business, he is also a Pulitzer Prize-nominated writer and reporter. His first book Overdrawn: The Bailout of American Savings warned people about the coming financial collapse - years before the word "bailout" became a household word.

Silicon Valley defense publications vie for his analysis. He's worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.

And even with decades of experience, Michael believes there has never been a moment in time quite like this.

Right now, medical breakthroughs that once took years to develop are moving at a record speed. And that means we are going to see highly lucrative biotech investment opportunities come in fast and furious.

To help you navigate the historic opportunity in biotech, Michael launched the Bio-Tech Profit Alliance.

His other publications include: Strategic Tech Investor, The Nova-X Report, Bio-Technology Profit Alliance and Nexus-9 Network.

Read full bio